AR
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
2 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Associate Counsel to the President
The White House; Director, US Office of Government Ethics.
Disclosed on LD-2 filings
Associate Counsel to the President
The White House; Director, US Office of Government Ethics
Disclosed on LD-2 filings
Career
LP
Specific issues
Work with Congress and the Administration to ensure that the Orphan Drug Exclusion from eligibility for negotiation under the Medicare Drug Price Negotiation Program allows products to remain excluded so long as their FDA approved uses are exclusively for rare diseases.